Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis

Biomed Pharmacother. 2024 May:174:116457. doi: 10.1016/j.biopha.2024.116457. Epub 2024 Mar 22.

Abstract

Ferroptosis, distinct from apoptosis, necrosis, autophagy, and other types of cell death, is a novel iron-dependent regulated cell death characterized by the accumulation of lipid peroxides and redox imbalance with distinct morphological, biochemical, and genetic features. Dysregulation of iron homeostasis, the disruption of antioxidative stress pathways and lipid peroxidation are crucial in ferroptosis. Ferroptosis is involved in the pathogenesis of several cardiovascular diseases, including atherosclerosis, cardiomyopathy, myocardial infarction, ischemia-reperfusion injury, abdominal aortic aneurysm, aortic dissection, and heart failure. Therefore, a comprehensive understanding of the mechanisms that regulate ferroptosis in cardiovascular diseases will enhance the prevention and treatment of these diseases. This review discusses the latest findings on the molecular mechanisms of ferroptosis and its regulation in cardiovascular diseases, the application of ferroptosis modulators in cardiovascular diseases, and the role of traditional Chinese medicines in ferroptosis regulation to provide a comprehensive understanding of the pathogenesis of cardiovascular diseases and identify new prevention and treatment options.

Keywords: Cardiovascular disease; Ferroptosis; Iron; Lipid peroxidation.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / pathology
  • Ferroptosis* / drug effects
  • Ferroptosis* / physiology
  • Humans
  • Iron / metabolism
  • Lipid Peroxidation / drug effects
  • Oxidative Stress / physiology

Substances

  • Iron